Consulting Services
For Investors
- Lucid Diligence Briefs
- Venture Capital
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
BioPharma and Tech News
LucidSearch
QuickAnswers

Contact Us

Search

guselkumab

Immunology

Immunology Today—November 19, 2025

This weekly Immunology newsletter features late-phase efficacy readouts,…

Immunology

Immunology Today: Zenas MS Deal, J&J FDA Approvals (Oct 8–15, 2025)

This week’s immunology news update includes Zenas BioPharma securing global…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Rare Disease News
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Neuroscience Today — December 17, 2025
Immunology Video Recap—December 17, 2025
Immunology Today—December 17, 2025
AI in Healthcare and Digital Health Video Recap —December 17, 2025
Lucid Diligence Brief: Sanofi and ADEL sign global licensing deal in Alzheimer’s

Tags

advanced therapies AI in Aesthetics AI in dermatology Amycretin Barinthus Biotherapeutics bioinformatics blood biomarkers cancer Chronic inflammation ckd corporate venture capital Dayra Therapeutics drug supply chain EAS 2025 Elranatamab EpiEndo Pharmaceuticals Eptinezumab ESMO 2021 gene editing gene therapy approval Heartnote heart valve treatment hematology HIV infection investment Kedrion metastatic uveal melanoma molecular design Mucosal immunity myocardial infarction NFTs in healthcare Nipah virus infection Nipocalimab non viral vectors noom oncology trials pharma prevention remote patient monitoring retinal ai Sema4 skin conditions tissue engineering unconventional trial designs Venous thromboembolism

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Neuroscience Today — December 17, 2025
Immunology Video Recap—December 17, 2025
Immunology Today—December 17, 2025
AI in Healthcare and Digital Health Video Recap —December 17, 2025
Lucid Diligence Brief: Sanofi and ADEL sign global licensing deal in Alzheimer’s

TAGS

advanced therapies AI in Aesthetics AI in dermatology Amycretin Barinthus Biotherapeutics bioinformatics blood biomarkers cancer Chronic inflammation ckd corporate venture capital Dayra Therapeutics drug supply chain EAS 2025 Elranatamab EpiEndo Pharmaceuticals Eptinezumab ESMO 2021 gene editing gene therapy approval Heartnote heart valve treatment hematology HIV infection investment Kedrion metastatic uveal melanoma molecular design Mucosal immunity myocardial infarction NFTs in healthcare Nipah virus infection Nipocalimab non viral vectors noom oncology trials pharma prevention remote patient monitoring retinal ai Sema4 skin conditions tissue engineering unconventional trial designs Venous thromboembolism

Consulting Services
For Investors
- Lucid Diligence Briefs
- Venture Capital
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
BioPharma and Tech News
LucidSearch
QuickAnswers

© 2025 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy